Xiao'er jiebiao
Hand, Foot And Mouth Disease
Children's Hospital of Fudan UniversityPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Hand, Foot And Mouth Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ribavirin Children's Hospital of Fudan University | Phase 4 | BB |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →